Missed at first Glanz: Glanzmann thrombasthenia initially misdiagnosed as Von Willebrand Disease.

Glanzmann thrombasthenia Menorrhagia Platelets Recombinant Factor VIIa Von Willebrand Disease

Journal

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
ISSN: 1473-0502
Titre abrégé: Transfus Apher Sci
Pays: England
ID NLM: 101095653

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 20 09 2018
revised: 05 11 2018
accepted: 26 11 2018
pubmed: 16 12 2018
medline: 5 4 2019
entrez: 16 12 2018
Statut: ppublish

Résumé

Glanzmann thrombasthenia (GT) is an autosomal recessive bleeding disorder caused by a defect in platelet integrin αIIbβ3. Given the rarity of the condition (1/1,000,000), assessment and diagnosis should be undertaken in a specialist centre. We report the case of a 34 year old woman with severe menorrhagia and a childhood diagnosis from another centre of Von Willebrand Disease. She had an extensive bleeding history, with epistaxis, menorrhagia and postoperative bleeding requiring multiple previous transfusions. Repeat haemostatic workup in our centre revealed normal Von Willebrand levels but abnormal platelet aggregation consistent with Glanzmann thrombasthenia. Antibody screening detected both anti-HLA and anti-αIIbβ3 antibodies, complicating subsequent haemostatic management. This case highlights the importance of diagnostic accuracy, the potential negative sequelae of misdiagnosis and subsequent therapeutic interventions.

Identifiants

pubmed: 30551951
pii: S1473-0502(18)30345-8
doi: 10.1016/j.transci.2018.11.008
pii:
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Pagination

58-60

Informations de copyright

Copyright © 2018 Elsevier Ltd. All rights reserved.

Auteurs

Dearbhla Doherty (D)

National Coagulation Centre, St James's Hospital, Dublin 8, Ireland.

Evelyn Singleton (E)

National Coagulation Centre, St James's Hospital, Dublin 8, Ireland.

Mary Byrne (M)

National Coagulation Centre, St James's Hospital, Dublin 8, Ireland.

Kevin Ryan (K)

National Coagulation Centre, St James's Hospital, Dublin 8, Ireland.

Niamh M O'Connell (NM)

National Coagulation Centre, St James's Hospital, Dublin 8, Ireland.

James S O'Donnell (JS)

National Coagulation Centre, St James's Hospital, Dublin 8, Ireland; Irish Centre for Vascular Biology, Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland.

Michelle Lavin (M)

National Coagulation Centre, St James's Hospital, Dublin 8, Ireland; Irish Centre for Vascular Biology, Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland. Electronic address: michellelavin@rcsi.ie.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH